JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
GeneDx Holdings
WGS
$2.35B
| $8.29M | ﹤0.01% |
107,891
+55,730
| +107% | +$3.89M |
|
2802
JPMorgan Active China ETF
JCHI
$14.9M
| $8.29M | ﹤0.01% |
190,000
-10,000
| -5% | -$464K |
|
2803
PUT
Pultegroup
PHM
$24.8B
| $8.27M | ﹤0.01% |
75,900
| – | – |
|
2804
PUT
Suncor Energy
SU
$77.5B
| $8.25M | ﹤0.01% |
231,200
+100,000
| +76% | +$3.85M |
|
|
STR
2805
DELISTED
Sitio Royalties
STR
| $8.24M | ﹤0.01% |
429,561
+172,819
| +67% | +$3.86M |
|
|
SWTX
2806
DELISTED
SpringWorks Therapeutics
SWTX
| $8.24M | ﹤0.01% |
227,935
-27,117
| -11% | -$947K |
|
2807
Ooma
OOMA
$572M
| $8.23M | ﹤0.01% |
585,020
-11,582
| -2% | -$154K |
|
2808
BridgeBio Pharma
BBIO
$15.7B
| $8.21M | ﹤0.01% |
299,214
-916,902
| -75% | -$23.7M |
|
2809
SunCoke Energy
SXC
$800M
| $8.21M | ﹤0.01% |
767,098
-84,953
| -10% | -$910K |
|
2810
Central Garden & Pet Co Class A
CENTA
$2.36B
| $8.2M | ﹤0.01% |
248,207
+37,393
| +18% | +$1.19M |
|
2811
CALL
Toll Brothers
TOL
$13.8B
| $8.2M | ﹤0.01% |
65,100
| – | – |
|
|
AHRT
2812
AH Realty Trust
AHRT
$506M
| $8.2M | ﹤0.01% |
801,274
+179,179
| +29% | +$1.95M |
|
2813
Lazard
LAZ
$4.4B
| $8.16M | ﹤0.01% |
158,604
-30,641
| -16% | -$1.64M |
|
2814
Main Street Capital
MAIN
$5.51B
| $8.15M | ﹤0.01% |
139,189
+37,640
| +37% | +$2.01M |
|
2815
PUT
Abercrombie & Fitch
ANF
$4.84B
| $8.15M | ﹤0.01% |
54,500
+54,000
| +10,800% | +$7.89M |
|
2816
Healthcare Services Group
HCSG
$1.48B
| $8.14M | ﹤0.01% |
700,651
-72,984
| -9% | -$832K |
|
2817
Euronet Worldwide
EEFT
$2.72B
| $8.13M | ﹤0.01% |
79,092
+8,174
| +12% | +$832K |
|
2818
Radware
RDWR
$1.23B
| $8.12M | ﹤0.01% |
360,375
+31,396
| +10% | +$719K |
|
2819
Skyward Specialty Insurance
SKWD
$2.45B
| $8.12M | ﹤0.01% |
160,647
+74,345
| +86% | +$3.61M |
|
2820
Harmony Biosciences
HRMY
$2.23B
| $8.12M | ﹤0.01% |
235,882
+5,454
| +2% | +$187K |
|
2821
CALL
Teck Resources
TECK
$31.2B
| $8.11M | ﹤0.01% |
200,000
| – | – |
|
2822
Intercorp Financial Services
IFS
$6.04B
| $8.11M | ﹤0.01% |
276,275
-12,020
| -4% | -$335K |
|
2823
Kyverna Therapeutics
KYTX
$503M
| $8.1M | ﹤0.01% |
2,166,437
-220,915
| -9% | -$1.06M |
|
2824
PUT
Chewy
CHWY
$9.12B
| $8.1M | ﹤0.01% |
241,900
+600
| +0.2% | +$18.7K |
|
2825
Capital Group Municipal Income ETF
CGMU
$6.58B
| $8.1M | ﹤0.01% |
300,740
-809,782
| -73% | -$22M |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.